Nottingham Forest trials blood test to study injury risk
Sport · First reported 9 Nov, 00:01 · Updated 00:19

Nottingham Forest and biotech company Entourage are running a 12-week study with the club’s 25-player men’s B-Team squad. Researchers will analyse blood samples alongside existing player information to investigate whether biological patterns could help identify injury risk and inform recovery.
- The study will analyse players’ blood twice a week and compare findings with training, workload and clinical information.
- Researchers will investigate whether protein patterns are associated with non-contact soft-tissue injuries and changes during recovery; the trial will assess whether the tests can predict or prevent injuries.
- Entourage will report the findings to Forest at the end of the study. The company says the technology could eventually complement performance statistics with biological information.
Summary written by Lux AI from 2 articles
Key facts
- Study duration
- 12 weeks
- Participants
- Nottingham Forest’s 25-player men’s B-Team squad
- Sampling schedule
- Blood samples twice a week
- Research partner
- Glasgow-based biotechnology company Entourage
- Reporting
- Entourage will report findings to Forest at the end of the study
Source spectrum
Left 0 · Centre 1 · Right 1 of 2 rated sources
Images from the coverage


All coverage
Coverage over time
LeftCentreRight
Articles per hour since first reported, by side.
Ownership
- Billionaire 50% (1)
- Unknown 50% (1)
Share of the 2 sources by owner type.